Correlation Between Effector Therapeutics and Vaccinex
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Vaccinex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Vaccinex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Vaccinex, you can compare the effects of market volatilities on Effector Therapeutics and Vaccinex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Vaccinex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Vaccinex.
Diversification Opportunities for Effector Therapeutics and Vaccinex
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Effector and Vaccinex is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Vaccinex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccinex and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Vaccinex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccinex has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Vaccinex go up and down completely randomly.
Pair Corralation between Effector Therapeutics and Vaccinex
Given the investment horizon of 90 days Effector Therapeutics is expected to under-perform the Vaccinex. In addition to that, Effector Therapeutics is 2.12 times more volatile than Vaccinex. It trades about -0.4 of its total potential returns per unit of risk. Vaccinex is currently generating about -0.01 per unit of volatility. If you would invest 678.00 in Vaccinex on August 29, 2024 and sell it today you would lose (309.00) from holding Vaccinex or give up 45.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 19.05% |
| Values | Daily Returns |
Effector Therapeutics vs. Vaccinex
Performance |
| Timeline |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Vaccinex |
Effector Therapeutics and Vaccinex Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Effector Therapeutics and Vaccinex
The main advantage of trading using opposite Effector Therapeutics and Vaccinex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Vaccinex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccinex will offset losses from the drop in Vaccinex's long position.| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
| Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |